Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.755
-0.015 (-0.31%)
Sep 16, 2025, 11:05 AM EDT - Market open
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 800 employees as of December 31, 2024. The number of employees increased by 300 or 60.00% compared to the previous year.
Employees
800
Change (1Y)
300
Growth (1Y)
60.00%
Revenue / Employee
$80,745
Profits / Employee
-$811,415
Market Cap
2.08B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 800 | 300 | 60.00% |
| Dec 31, 2023 | 500 | 0 | - |
| Dec 31, 2022 | 500 | 100 | 25.00% |
| Dec 31, 2021 | 400 | 69 | 20.85% |
| Dec 31, 2020 | 331 | 131 | 65.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RXRX News
- 7 days ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 12 days ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 20 days ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Recursion Pharmaceuticals, Inc. (RXRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th - GlobeNewsWire
- 7 weeks ago - How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma - Benzinga
- 2 months ago - Top 2 Health Care Stocks You May Want To Dump This Quarter - Benzinga